Drug Information

Drug General Information
Drug ID
D0Y3JI
Former ID
DIB003176
Drug Name
DG-17
Synonyms
DG-35; Nar DG-35 Prodrug; DG-35-VIII
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 2 [550282]
Company
Narhex Life Sciences Ltd
Structure
Download
2D MOL

3D MOL
Canonical SMILES
n1c(C(=O)N[C@H](C(=O)N[C@H]([C@H](CN(NC(=O)OC(C)(C)C)C(<br />C)C)O)Cc2ccccc2)CC(=O)N)ccc2c1cccc2
CAS Number
CAS 155073-99-7
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [544059]
References
Ref 550282Narhex Life Sciences Limited announced a successful capital raising via a combined Rights Issue and Placement offering. 21 May 2007.
Ref 544059Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development. AIDS. 1999 April 16; 13(6): 661-667.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.